COLL

Collegium Pharmaceutical, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$150m30-Sep-2610-Q filed 05-Nov-26
Remaining authorization$100m30-Sep-2610-Q filed 05-Nov-26
Program expiry31-Dec-2630-Sep-2610-Q filed 05-Nov-26
Repurchased last quarter$031-Aug-2610-Q filed 05-Nov-26
Has used an ASRYes13-Aug-2610-Q filed 05-Nov-26

Programs

Authorized onAuthorizedRemainingExpiresTerms
Not found in filings$150m$100m31-Dec-26In July 2025, our Board of Directors authorized a new share repurchase program for the repurchase of up to $150.0 million of shares of our common stock through December 31, 2026 (the “2025-2026 Repurchase Program”).10-Q filed 05-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. ≈$388.4k
    Apr ’26
  2. May ’26
  3. Jun ’26
  4. Jul ’26
  5. ≈$0
    Aug ’26

Amount unknown: not in the filings we hold yet, or not stated. Hover for which.

Month endedSharesWithheld & otherASR sharesAvg price≈ ValueSource
31-Aug-2603,6901,556,420$25.70$010-Q filed 05-Nov-26
30-Jun-262,7282,728—$34.80$94.9k10-Q filed 06-Aug-26
31-May-264,5024,502—$35.81$161.2k10-Q filed 06-Aug-26
30-Apr-2610,95110,951—$35.47$388.4k10-Q filed 06-Aug-26

Outstanding ASR

Track this ASR
Size
$50m
Bank
Not found in filings
Started
13-Aug-26
Upfront shares
1.6m
Final settlement
Not found in filings

From 10-Q filed 05-Nov-26. Tracking needs your confirmation's exact dates and discount, which filings don't disclose.

Accelerated share repurchases

AnnouncedStatusSizeBanksInitial sharesFinal sharesAvg priceSource
13-Aug-26Outstanding $50m—1,556,420——10-Q filed 05-Nov-26
09-May-25Completed July 2025$25m—692,281129,847—10-Q filed 05-Nov-26
10-Q filed 05-Nov-26
Filings through 30-Sep-26· checked 18-Nov-26